{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:08:12Z","timestamp":1791385692187,"version":"4.3.3"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1378\/chest.11-0801","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T23:47:23Z","timestamp":1323388043000},"page":"614-621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Correlation of Cough With Disease Activity and Treatment With Cyclophosphamide in Scleroderma Interstitial Lung Disease"],"prefix":"10.1016","volume":"142","author":[{"given":"Arthur C.","family":"Theodore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hong","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Elashoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P.","family":"Tashkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1378\/chest.11-0801_bib1","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1378\/chest.11-0801_bib2","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1164\/rccm.200702-326OC","article-title":"Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease","volume":"176","author":"Tashkin","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1378\/chest.11-0801_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0034-5687(98)00076-0","article-title":"Afferent receptors in the airways and cough","volume":"114","author":"Widdicombe","year":"1998","journal-title":"Respir Physiol"},{"issue":"3","key":"10.1378\/chest.11-0801_bib4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1183\/09031936.98.11030702","article-title":"Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease","volume":"11","author":"Lalloo","year":"1998","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1378\/chest.11-0801_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000194614","article-title":"Influence of lung stretch receptors on the cough reflex in rabbits","volume":"45","author":"Han\u00e1cek","year":"1984","journal-title":"Respiration"},{"issue":"5\u20136","key":"10.1378\/chest.11-0801_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/pulp.1996.0041","article-title":"The role of capsaicin-sensitive C-fibre afferent nerves in the cough reflex","volume":"9","author":"Karlsson","year":"1996","journal-title":"Pulm Pharmacol"},{"issue":"10","key":"10.1378\/chest.11-0801_bib7","first-page":"1520","article-title":"High resolution computed tomography in early scleroderma lung disease","volume":"18","author":"Warrick","year":"1991","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1378\/chest.11-0801_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1148\/radiology.188.2.8327704","article-title":"Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage","volume":"188","author":"Remy-Jardin","year":"1993","journal-title":"Radiology"},{"issue":"2 pt 1","key":"10.1378\/chest.11-0801_bib9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1164\/ajrccm.154.2.8756813","article-title":"Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung","volume":"154","author":"Behr","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.11-0801_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0002-9343(90)90425-D","article-title":"Evaluation and management of scleroderma lung disease using bronchoalveolar lavage","volume":"88","author":"Silver","year":"1990","journal-title":"Am J Med"},{"issue":"4","key":"10.1378\/chest.11-0801_bib11","first-page":"574","article-title":"Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function","volume":"133","author":"Wallaert","year":"1986","journal-title":"Am Rev Respir Dis"},{"issue":"10","key":"10.1378\/chest.11-0801_bib12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/ard.58.10.635","article-title":"Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis","volume":"58","author":"Witt","year":"1999","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1378\/chest.11-0801_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1378\/chest.07-2444","article-title":"High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease","volume":"134","author":"Goldin","year":"2008","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.11-0801_bib14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1378\/chest.09-0108","article-title":"Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study","volume":"136","author":"Goldin","year":"2009","journal-title":"Chest"},{"issue":"6","key":"10.1378\/chest.11-0801_bib15","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/art.22696","article-title":"Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression","volume":"56","author":"Goh","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1378\/chest.11-0801_bib16","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/art.23077","article-title":"Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease","volume":"56","author":"Mittoo","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1378\/chest.11-0801_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1148\/radiology.161.3.3786716","article-title":"Traction bronchiectasis in end-stage pulmonary fibrosis","volume":"161","author":"Westcott","year":"1986","journal-title":"Radiology"},{"issue":"5","key":"10.1378\/chest.11-0801_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1378\/chest.11-0801_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2214\/ajr.184.2.01840613","article-title":"Isolated diffuse ground-glass opacity in thoracic CT: causes and clinical presentations","volume":"184","author":"Miller","year":"2005","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1378\/chest.11-0801_bib20","first-page":"84","article-title":"The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis","volume":"25","author":"Furst","year":"1998","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1378\/chest.11-0801_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1164\/rccm.200705-655OC","article-title":"Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease","volume":"177","author":"Strange","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1378\/chest.11-0801_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1378\/chest.97.1.75","article-title":"The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis","volume":"97","author":"Petty","year":"1990","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.11-0801_bib23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/art.20787","article-title":"Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study","volume":"52","author":"Khanna","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1378\/chest.11-0801_bib24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"6","key":"10.1378\/chest.11-0801_bib25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1378\/chest.85.6.751","article-title":"The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes","volume":"85","author":"Mahler","year":"1984","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.11-0801_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.amjmed.2010.12.009","article-title":"Adverse events during the Scleroderma Lung Study","volume":"124","author":"Furst","year":"2011","journal-title":"Am J Med"},{"issue":"6","key":"10.1378\/chest.11-0801_bib27","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/art.20265","article-title":"Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis","volume":"50","author":"Clements","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1378\/chest.11-0801_bib28","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1136\/ard.2007.069518","article-title":"Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis","volume":"66","author":"Clements","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1378\/chest.11-0801_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/ajrccm\/141.2.301","article-title":"Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity","volume":"141","author":"Miller","year":"1990","journal-title":"Am Rev Respir Dis"},{"issue":"5 suppl 62","key":"10.1378\/chest.11-0801_bib30","first-page":"S26","article-title":"A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients","volume":"28","author":"Kim","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1378\/chest.11-0801_bib31","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/ard.2004.033076","article-title":"Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations","volume":"64","author":"Kowal-Bielecka","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1378\/chest.11-0801_bib32","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s11136-006-0018-8","article-title":"Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients","volume":"15","author":"Cole","year":"2006","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1378\/chest.11-0801_bib33","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/art.22580","article-title":"Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study","volume":"56","author":"Khanna","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212605042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212605042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:31:04Z","timestamp":1757917864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369212605042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0012369212605042"],"URL":"https:\/\/doi.org\/10.1378\/chest.11-0801","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of Cough With Disease Activity and Treatment With Cyclophosphamide in Scleroderma Interstitial Lung Disease","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.11-0801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1378\/chest.12-0170","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}